近年来，我国化妆品产业已迈入蓬勃发展的快车道。据中国香料香精化妆品工业协会联合相关机构统 计，2024年我国化妆品市场交易总额达10738.22亿元，同比增长2.8%；其中国产品牌市场份额持续扩 大，占比达55.2%。 中关村物联网产业联盟副秘书长袁帅对《证券日报》记者表示："我国化妆品产业正处于快速发展与转 型升级的关键时期。从整体来看，产业规模持续扩大，国际竞争力逐步增强。但繁荣发展的背后，也存 在创新能力不足、品牌建设相对滞后等问题。" 11月17日，国家药品监督管理局（以下简称"国家药监局"）发布《关于深化化妆品监管改革促进产业高 质量发展的意见》（以下简称《意见》），其中要求加大化妆品产业创新支持力度。《意见》还就"畅 通新功效化妆品注册渠道""鼓励化妆品新品在中国首发""促进化妆品银发经济发展"等六个方面提出针 对性意见。 中国企业联合会资委会委员、高级经济师董鹏对《证券日报》记者表示，《意见》通过完善监管体系、 强化创新支持等举措，为化妆品产业的健康发展构建了系统化路径。这不仅有助于深化化妆品监管改 革，还能更好地满足人民群众对健康美、个性化美的深层需求，实现"美丽经济"与"品质生活"的协同发 ...

Core Insights - The National Medical Products Administration has released opinions to deepen cosmetic regulation reform and promote high-quality industry development, emphasizing increased support for the industry and fostering competitive domestic brands [1][5][6] - The domestic cosmetics market is projected to exceed 1 trillion yuan in transaction volume by 2024, with domestic brands capturing 55.2% market share [1] - The rise of domestic cosmetics is attributed to the integration of traditional Chinese culture and innovative product development, appealing to consumers' cultural values [2][3] Industry Trends - The "Double 11" shopping festival showcased strong performance for domestic cosmetics, with 5 out of the top 10 beauty brands on Douyin being Chinese [2] - Consumers are increasingly seeking products that offer cultural value and emotional resonance beyond basic functionality [2] Innovation and Technology - As of mid-2023, 80 new cosmetic raw materials have been registered, with a year-on-year growth of approximately 80%, indicating strong momentum in local raw material development [3] - Chinese companies dominate the global hyaluronic acid market, accounting for 80% of total sales, with innovative production methods enhancing product efficacy [3] Policy Support - The recent policy opinions aim to stimulate innovation, reduce corporate burdens, and optimize the market environment through scientific regulation [6][7] - Local governments are implementing supportive measures, such as financial incentives for key laboratories and initiatives to promote "Shanghai manufacturing" [7] Future Outlook - The continuous improvement of regulatory frameworks and local policies is expected to support the transition from a "cosmetic manufacturing powerhouse" to a "cosmetic strong nation" [7] - The industry is encouraged to leverage cultural elements and scientific research to enhance competitiveness and expand globally [4][8]

Core Viewpoint - The approval of "Anse® Luoshen Zhu" as the world's first high molecular coloring agent for cosmetics marks a significant breakthrough in China's cosmetic raw material sector, transitioning from a follower to a leader in coloring technology [1][10]. Group 1: Product Approval - "Anse® Luoshen Zhu" is the first domestically developed cosmetic raw material approved by the National Medical Products Administration (NMPA) since the implementation of the new regulations in 2021 [1]. - The product received its registration number "Guo Zhuang Yuan Zhu Zi 20250002" and was officially approved on October 30, 2025 [2]. Group 2: Technological Innovation - The product utilizes a fourth-generation water-based polyurethane synthesis technology, embedding color groups in a stable structure that exceeds skin permeability thresholds, thus addressing safety concerns associated with traditional small molecular coloring agents [3]. - This innovation establishes a new technical pathway for "non-percutaneous coloring," significantly enhancing safety in cosmetic applications [3]. Group 3: Safety and Performance Standards - "Anse® Luoshen Zhu" is characterized by high molecular weight, ensuring that coloring agents do not penetrate the skin barrier, effectively eliminating transdermal absorption risks [4]. - The product exhibits excellent performance in terms of migration resistance, solvent resistance, and thermal stability, maintaining color stability across various formulations [4]. - The manufacturing process is environmentally friendly, free from organic solvents and toxic heavy metals, aligning with sustainable development principles [4]. Group 4: Regulatory Support - The successful registration of "Anse® Luoshen Zhu" reflects the NMPA's commitment to supporting innovation in new raw materials through scientific regulation and precise evaluation [6]. - The regulatory framework has facilitated the approval process for high-tech raw materials, demonstrating a pragmatic approach to innovation [6]. Group 5: Future Development - The approval of "Anse® Luoshen Zhu" lays a solid foundation for the development of subsequent products in the "Anse®" series, with plans for further research and registration of additional colorants [8]. - The company aims to meet the diverse safety coloring needs of the cosmetics industry by introducing more reliable high molecular coloring agents in the future [8].

Core Insights - Two new cosmetic raw materials have been approved by the National Medical Products Administration (NMPA), marking significant advancements in China's cosmetic industry [1] Group 1: New Raw Materials - The first new raw material, 2-(4'-Azo-benzene polyoxyethylene ether)-4-methyl benzothiazole-based waterborne polyurethane, is the world's first polymer coloring agent registered for use in cosmetics, developed independently in China [1] - This new polymer coloring agent can be used in leave-on and rinse-off cosmetics, excluding products with potential inhalation exposure risks [1] - The second new raw material, dimethoxy toluene propyl hydroquinone, is registered as a whitening agent and can be used in creams, lotions, gels, masks, and other skincare products, also excluding those with potential inhalation exposure risks [1] Group 2: Industry Impact - The approval of these two raw materials represents a historic leap for China in the field of cosmetic coloring technology, transitioning from a "follower" to a "leader" [1] - Since the implementation of the "Regulations on the Registration and Filing of New Cosmetic Raw Materials" in 2021, this is the second registered new raw material approved, and the first domestically developed one [1] - Following the release of the "Several Provisions to Support Innovation in Cosmetic Raw Materials" by the NMPA in January, 125 new raw materials have completed registration and filing, reflecting a year-on-year increase of 101.64%, which significantly promotes high-quality innovation in the cosmetic industry [1]

Core Insights - The Sichuan Province Cosmetics High-Quality Industry Development Conference was held in Chengdu, focusing on the theme "Shuzhuang Zhiyun · Intelligent Manufacturing Future" to explore high-quality development paths for the cosmetics industry in Sichuan [1] - Good Doctor Group participated as a brand representative, showcasing its strength in beauty raw materials and receiving high recognition for its technical research achievements [1] Group 1: Product Development - Good Doctor Group's research manager, Pu Qianqian, presented on "A Life Peptide Derived from the American Cockroach," detailing the development process of the hexapeptide-117 ingredient from three dimensions: mechanism, efficacy data, and toxicological safety [3] - The research adhered to a "Four Questions" philosophy, focusing on efficacy, the active components, the mechanism of action, and the process of efficacy [5] - Hexapeptide-117 was developed using a combination of molecular biology and clinical validation, integrating traditional medicine with modern scientific interpretation [5] Group 2: Efficacy and Testing - In vitro testing on a 3D epidermal skin model showed that hexapeptide-117 significantly increased the levels of filaggrin (FLG) and loricrin (LOR), which are crucial for skin barrier function [6] - The ingredient provides a gentle and effective soothing solution for sensitive skin experiencing redness and discomfort due to external stimuli [6] - Human efficacy tests indicated that subjects with sensitive skin using a serum containing 0.1% hexapeptide-117 for 28 days experienced better results compared to the control group [6] Group 3: Innovation and Market Impact - Hexapeptide-117 represents a new cosmetic raw material that combines natural wisdom with modern technology, marking an innovative achievement in the skincare industry [6] - The successful registration of this new ingredient in August signifies the emergence of a safer and more effective skincare component [5][6] - This development opens new avenues for innovation in the cosmetics raw material sector, enhancing consumer choices for skin health [6]

Core Insights - Bayer's new patented ingredient, Tiannmingduo®630, is the first inhibitor based on human tyrosinase screening, aimed at suppressing melanin production from the source [1][3] - The introduction of the Chinese trademark signifies the ingredient's localization for Chinese consumers and strengthens intellectual property protection [3] - Tiannmingduo®630 is a result of over 20 years of research and development, reflecting the strategy of "driving global R&D with Chinese demand" [3] Product Launch and Market Strategy - Bayer has launched 12 products containing Tiannmingduo®630, covering various skincare segments including mass market, dermatological, high-end skincare, and professional medical aesthetics [1] - The ingredient received approval as the first new whitening ingredient under the Cosmetic Supervision and Administration Regulations, indicating a significant regulatory milestone [4] - The second-generation light-activated essence featuring Tiannmingduo®630 was globally launched in Shanghai, marking a transition from cross-border to local sales [4] Research and Development - The development of Tiannmingduo®630 involved overcoming challenges in expressing recombinant human tyrosinase over 15 years, screening from over 50,000 molecules [3] - The ingredient has completed a full set of toxicological safety assessments and has been published in multiple SCI papers [3] Regulatory and Industry Support - The ingredient's market entry was facilitated by supportive policies, including the establishment of a synchronized application mechanism for new raw materials and related products [4] - Bayer emphasizes data-driven claims in the competitive beauty market and intends to combat false advertising related to unverified ingredients [4]

Core Viewpoint - The Chinese beauty and cosmetics industry has transitioned from "incremental competition" to "stock game," shifting from channel-driven to brand-driven strategies, with significant advancements in raw material innovation, efficacy verification, and technology transformation [3]. Group 1: Market Overview - The market size of China's cosmetics industry has exceeded 1 trillion yuan for two consecutive years since 2023, making it the largest cosmetics consumption market globally [3]. - In 2024, the total transaction volume of China's cosmetics market is projected to reach 1,073.82 billion yuan, reflecting a year-on-year growth of 2.8% [6]. Group 2: Industry Challenges - The core driving force of the cosmetics market is the raw materials, with domestic companies primarily focused on mid-to-low-end markets due to insufficient R&D investment and outdated production processes [6][9]. - High-end raw materials are still heavily reliant on imports, highlighting the need for domestic companies to enhance their R&D capabilities [6]. Group 3: Technological Advancements - Many domestic beauty companies are investing in R&D to develop new raw materials, with examples including the establishment of an intelligent bio-fermentation raw material factory by the natural brand Chando [8]. - Companies like Huaxi Biological have achieved breakthroughs in synthetic biology technology, allowing for precise control over hyaluronic acid molecular weight [9]. Group 4: Government Support - The Chinese government is encouraging innovation in upstream raw material development, implementing policies such as "immediate reporting and review" for new cosmetic raw materials [10]. - In September, Shanghai introduced measures to promote high-quality development in the cosmetics industry, offering substantial subsidies for new raw material development [10]. Group 5: Collaboration and Innovation - The industry is focusing on systematic and foundational innovation, with companies like Yunnan Betaini emphasizing the integration of medical research and technological innovation to build strong brand barriers [12]. - Collaborative projects, such as the establishment of a joint laboratory for artemisinin and traditional Chinese medicinal plants by Shanghai Jahwa and the Chinese Academy of Medical Sciences, aim to enhance the application of artemisinin in skincare [17].

Core Insights - The Chinese fragrance and cosmetics industry is transitioning from "incremental competition" to "stock game" dynamics, with a shift from channel-driven to brand-driven competition [1] - The market size of China's cosmetics industry has exceeded 1 trillion yuan for two consecutive years, making it the largest cosmetics consumer market globally [1] - Companies are focusing on technological innovation, brand value reconstruction, and collaborative networks to enhance their competitiveness in the global value chain [1] Industry Trends - The Chinese cosmetics market is projected to reach a total transaction value of 1,073.82 billion yuan in 2024, reflecting a year-on-year growth of 2.8% [3] - The core driving force of the cosmetics market is the innovation in raw materials, with domestic companies primarily concentrated in the mid-to-low-end sectors [3] - Many local beauty companies are investing in R&D to develop proprietary raw materials, moving away from reliance on imports [5][6] Technological Advancements - Companies like Huaxi Biological Technology are emphasizing the importance of core technology and R&D capabilities to survive in a competitive market [2] - Natural堂 has developed over 20 proprietary raw materials, showcasing a shift from dependence on imports to self-sufficiency in high-quality ingredients [6] - The Chinese government is implementing policies to support innovation in cosmetic raw materials, including expedited review processes for new ingredients [7] Collaborative Efforts - The establishment of partnerships between research institutions and cosmetic companies aims to bridge the gap between laboratory innovations and market applications [9][12] - The launch of the "Beautiful Health Medical Research and Enterprise Transformation Center" in Nanjing signifies a commitment to enhancing collaboration in the industry [9] - Shanghai Jahwa's collaboration with the Chinese Academy of Traditional Chinese Medicine highlights the potential of traditional ingredients like artemisinin in skincare applications [11]

新原料备案过程中，海南省药监局积极提供指导服务，组织专业技术团队对企业开展"一对一"辅 导，全程跟踪备案进度，协助企业完善申报材料，确保原料安全性和合规性。省药监局相关负责人表 示，将继续优化备案服务机制，支持更多企业开发利用海南特色动植物资源，推动本省化妆品产业创新 发展。 海南日报讯(海南日报全媒体见习记者 王泽宇 记者 王晓曈)近日，海南化妆品产业迎来重要突 破。位于东方市的海南鳄珍鳄鱼产业科技有限公司申报的"鳄鱼油"化妆品新原料已通过国家药监局备 案，成为我省首个成功备案的化妆品新原料，标志着海南化妆品原料创新迈出关键一步。 据悉，此次鳄鱼油新原料的成功备案，是海南充分发挥地方资源特色，促进产业转型升级的具体成 果，将为海南化妆品产业高质量发展注入新动能。 海南鳄珍鳄鱼产业科技有限公司是东方鳄鱼产业龙头企业，集鳄鱼养殖、研发、深加工与销售于一 体，2024年全产业链年产值突破1.5亿元，其开发的美容日化、皮具、营养品等系列产品销售覆盖全 国，本次"鳄鱼油"的研发也是该企业在化妆品原料领域的全新尝试。 根据《化妆品监督管理条例》规定，在我国境内首次使用于化妆品的天然或人工原料属于化妆品新 原料。此次备案 ...

Core Viewpoint - The article emphasizes the acceleration of innovation in China's cosmetic raw materials through regulatory reforms, particularly the "immediate reporting and review" system, which aims to enhance the industry's competitiveness on a global scale [2][6][12]. Regulatory Reforms - The National Medical Products Administration (NMPA) has introduced the "immediate reporting and review" system for new cosmetic raw materials, significantly shortening the approval process and encouraging innovation [6][12]. - A draft opinion on deepening cosmetic regulatory reforms has been prepared, indicating a shift towards a more systematic and high-quality regulatory framework [4][8]. - The NMPA is focusing on high-value innovative raw materials, providing personalized support to encourage genuine innovation [7][12]. Industry Growth - The cosmetic market in China reached a total transaction value of 107.38 billion yuan in 2024, with online sales accounting for 55.2% of the market share among the top 100 brands [8]. - As of August 20, 2025, there are 6,093 cosmetic production enterprises and over 2.24 million registered and filed cosmetic products, indicating rapid industry expansion [9]. Innovation and Market Dynamics - The NMPA's reforms are expected to lower innovation costs and time, allowing companies to respond more quickly to market demands and convert innovations into competitive advantages [12][14]. - The transition from a regulatory ordinance to a legal framework signifies an elevation of the cosmetic industry's status within the national economy [15]. Collaborative Governance - The NMPA aims to establish a governance framework that includes corporate responsibility, government regulation, industry self-discipline, and public participation to foster a healthy innovation ecosystem [11]. - The China Fragrance and Cosmetic Industry Association plays a crucial role in this governance structure, contributing to safety assessments and technological advancements in the industry [11].